| 摘要 |
The present invention relates to T-cell receptors T(CRs ) having an affinity (K) of less than or equal to 3 μM, and/or an off-rate (k) of 1x10Sor slower, for the AAGIGILTV-HLA-A*0201 complex. Such TCRs are useful, either alone or associated with a therapeutic agent, for targeting cancer cells presenting that complex. |
